Atlas Trials

A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E

Clinical trial NCT01305109 · UNKNOWN

Trial details

NCT number
NCT01305109
Sponsor
Bharat Biotech International Limited
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Viral Gastroenteritis Due to Rotavirus
Start date
2011-03-01
Primary completion
2013-12-01
Enrollment
6800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.